News Sentiment

DRTS sentiment intelligence

Alpha Tau Medical Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 13.55 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+6.6% over one week, +38.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction 6.6% Price confirming higher
Trend fit Trend active 38.5% over four weeks
Fair value 232.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 39
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 19
Market source 6
Investing.com 5
TradingView 5
GlobeNewswire 4
Simply Wall Street 3
simplywall.st 3
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 15
Analyst action 4
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
Investing.com Direct company coverage

Alpha Tau Medical stock hits 52-week high at $11.64

Alpha Tau Medical (DRTS) stock reached a 52-week high of $11.64, reflecting a significant 266.03% year-on-year increase and bringing its market capitalization to approximately $1.04 billion. Despite this surge, InvestingPro data suggests the stock might be overvalued. Recent deve

Tone
Positive 70/100
Event
Market update
Published
30 Jun 2026 13:40
Source
Investing.com
Sahm Direct company coverage

Why Alpha Tau Medical (DRTS) Is Up 11.2% After First Alpha DaRT Brain-Tumor Procedure News

Alpha Tau Medical (DRTS) saw an 11.2% stock price increase following the successful first international Alpha DaRT treatment of a glioblastoma patient in Israel. This procedure, which used Alpha DaRT’s brain-specific delivery system, marks a significant milestone and extends the

Tone
Positive 66/100
Event
Market update
Published
28 Jun 2026 22:40
Source
Sahm